Dr. Sudarshan Rajagopal

I take care of patients with pulmonary hypertension (PH). I also research signaling pathways that are altered in the development of PH in rodent models of the disease. PH covers a wide spectrum of diseases, from the rare pulmonary arterial hypertension (prevalence of 15 in one million) to complications of more common heart and lung disease. PH typically leads to complications through its effects on the heart, leading to heart failure. At the Duke Center for Pulmonary Vascular Disease we see a number of patients with PH and offer all available therapies, including continuous intravenous infusion, inhaled therapies, and surgical options.

Dr. Rajagopal is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, Embolectomy, and Angioplasty.

Dr. Rajagopal is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Cardiovascular Disease. He is actively involved in clinical research, co-authoring 114 peer reviewed articles and participating in 8 clinical trials.